Announcement on the Wholly-Owned Subsidiary Receiving the CEP Certificate for Everolimus API

About this update from Zhejiang Hisun Pharmaceutical Co., Ltd. Class A

Announcement on the Wholly-Owned Subsidiary Receiving the CEP Certificate for Everolimus API The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Hisun Pharmaceutical Co., Ltd. Class A